Breaking News Instant updates and real-time market news.

HBI

Hanesbrands

$24.40

-0.08 (-0.33%)

08:59
11/28/16
11/28
08:59
11/28/16
08:59

Hanesbrands remains a top idea at Morgan Stanley

Morgan Stanley analyst Jay Sole said Hanesbrands remains a top Overweight idea following recent management meetings. SOle said Hanesbrands is on trace to meet its FY16 cash flow guidance, M&A integrations continue, organic growth rates should improve in Q4 and FY17, and its supply chain has flexibility if trade rules change. The analyst expects a positive Q4 report and said discounted cash flow analysis suggests Hanesbrands is worth $34.

HBI Hanesbrands
$24.40

-0.08 (-0.33%)

07/29/16
UBSW
07/29/16
NO CHANGE
Target $37
UBSW
Buy
Hanesbrands earnings quality concerns overblown, says UBS
UBS believes Hanesbrands has one of the best catalyst calendars in the second half of the year and noted its price to earnings ratio is at a three year trough. The firm sees a favorable risk/reward after shares pulled back to reflect investor concerns over its earnings quality. UBS views those concerns as overblown and reiterated its Buy rating and $37 price target on Hanesbrands shares.
08/03/16
BMUR
08/03/16
NO CHANGE
Target $35
BMUR
Buy
Hanesbrands buy thesis remains intact, says Brean Capital
Brean Capital said they remain constructive on Hanesbrands following soft Q2 results as they believe their buy thesis remains intact. The firm sees an acceleration of core revenues, increased manifestation of acquisition synergies, improving inventory and free cash flow, and a successful succession plan to a new CEO. Brean Capital reiterated its Buy rating and lowered its price target to $35 from $37 on Hanesbrands shares.
10/12/16
COWN
10/12/16
DOWNGRADE
Target $27
COWN
Market Perform
Hanesbrands downgraded to Market Perform from Outperform at Cowen
Cowen analyst John Kernan downgraded Hanesbrands to Market Perform and lowered its price target to $27 from $33. The analyst believes consensus estimates of 32% earnings growth in 2018 from 2016 appear optimistic given industry dynamics. Kernan lowered his FY17 sales estimate slightly below consensus and now models total sales growth of +9% versus consensus of +10% and believes additional margin expansion may prove difficult as trends indicate North American department store/sporting goods, broadlines and specialty store community are reluctant to commit to inventory buys from vendors ahead of season.
10/28/16
BMUR
10/28/16
NO CHANGE
Target $35
BMUR
Buy
Hanesbrands risk/reward remains favorable, says Brean Capital
Brean Capital analyst Eric Tracy said the risk/reward for Hanesbrands remains favorable following its Q3 results. The analyst cited the expected acceleration of core revenues, increasing manifestation of acquisition synergies, and improving inventory and operating cash flow. Tracy reiterated his Buy rating and $35 price target on Hanesbrands shares.

TODAY'S FREE FLY STORIES

NGD

New Gold

, GILD

Gilead

$70.48

2.98 (4.41%)

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Options
Unusually active option classes on open June 23rd »

Unusual total active…

NGD

New Gold

GILD

Gilead

$70.48

2.98 (4.41%)

ORCL

Oracle

VRX

Valeant

AMD

AMD

$14.38

0.4 (2.86%)

DIS

Disney

SLV

iShares Silver Trust

CAT

Caterpillar

COST

Costco

$159.79

-3.36 (-2.06%)

TWTR

Twitter

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 19

    Jul

  • 08

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

STML

Stemline

$8.50

0.15 (1.80%)

09:39
06/23/17
06/23
09:39
06/23/17
09:39
Hot Stocks
Stemline presents updated stage 1 and 2 data from SL-401 trial »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Sep

LGF

Use LGF.A, LGF.B

09:39
06/23/17
06/23
09:39
06/23/17
09:39
Conference/Events
Use LGF.A, LGF.B management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

INN

Summit Hotel Properties

09:38
06/23/17
06/23
09:38
06/23/17
09:38
Conference/Events
Summit Hotel Properties management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 13

    Jul

IMGN

ImmunoGen

$5.82

-0.2 (-3.32%)

09:38
06/23/17
06/23
09:38
06/23/17
09:38
Conference/Events
ImmunoGen management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

REGN

Regeneron

$526.53

4.51 (0.86%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Hot Stocks
Breaking Hot Stocks news story on Regeneron »

Regeneron down 4.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$14.68

0.48 (3.38%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Periodicals
Several private equity firms have reached out to Etsy, Dealreporter says »

While Etsy has not been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Technical Analysis
Technical View: Caterpillar slips lower, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQY

HealthEquity

$51.05

-0.39 (-0.76%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Conference/Events
HealthEquity management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

APLP

Archrock Partners LP

$13.66

0.61 (4.67%)

09:35
06/23/17
06/23
09:35
06/23/17
09:35
Downgrade
Archrock Partners LP rating change  »

Archrock Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
06/23/17
06/23
09:35
06/23/17
09:35
General news
U.S. new home sales preview: »

U.S. new home sales…

AROC

Archrock

09:34
06/23/17
06/23
09:34
06/23/17
09:34
Downgrade
Archrock rating change  »

Archrock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRE

Washington REIT

09:32
06/23/17
06/23
09:32
06/23/17
09:32
Conference/Events
Washington REIT management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 28

    Jul

  • 27

    Oct

09:30
06/23/17
06/23
09:30
06/23/17
09:30
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

June PMI Composite Flash…

09:30
06/23/17
06/23
09:30
06/23/17
09:30
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

June PMI Composite Flash…

ADHD

Alcobra

, AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

09:29
06/23/17
06/23
09:29
06/23/17
09:29
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Alcobra (ADHD),…

ADHD

Alcobra

AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

SNCR

Synchronoss

$12.18

1.53 (14.37%)

BBRY

BlackBerry

$11.06

0.41 (3.85%)

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

BLCM

Bellicum Pharmaceuticals

$13.98

1.33 (10.51%)

BLUE

bluebird bio

$118.50

-1.8 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 23

    Jun

  • 29

    Jun

  • 26

    Sep

RIO

Rio Tinto

, GLNCY

Glencore

$7.10

0.05 (0.71%)

09:29
06/23/17
06/23
09:29
06/23/17
09:29
Hot Stocks
Glencore raises offer for Rio Tinto's Coal & Allied to $2.675B plus royalties »

Glencore (GLNCY)…

RIO

Rio Tinto

GLNCY

Glencore

$7.10

0.05 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$149.69

0.27 (0.18%)

09:28
06/23/17
06/23
09:28
06/23/17
09:28
Conference/Events
Stifel medical technology analysts hold an analyst/industry conference call »

Research Team discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Jun

PAAS

Pan American Silver

$16.95

0.51 (3.10%)

09:28
06/23/17
06/23
09:28
06/23/17
09:28
Conference/Events
Pan American Silver management to meet with JPMorgan »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

BAESY

BAE Systems

$34.19

-0.635 (-1.82%)

09:25
06/23/17
06/23
09:25
06/23/17
09:25
Downgrade
BAE Systems rating change  »

BAE Systems downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
06/23/17
06/23
09:25
06/23/17
09:25
General news
Fed funds futures are unchanged to modestly lower »

Fed funds futures are…

CRNCY

Cairn Energy

$4.44

0.15 (3.50%)

09:24
06/23/17
06/23
09:24
06/23/17
09:24
Conference/Events
Cairn Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

RHHBY

Roche

$32.30

-0.3 (-0.92%)

09:22
06/23/17
06/23
09:22
06/23/17
09:22
Hot Stocks
Roche receives FDA approval for Elecsys HIV combi PT assay »

Roche announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

P

Pandora

, SIRI

SiriusXM

09:22
06/23/17
06/23
09:22
06/23/17
09:22
Recommendations
Pandora, SiriusXM analyst commentary  »

Pandora selloff since…

P

Pandora

SIRI

SiriusXM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ASML

ASML

$130.02

-0.41 (-0.31%)

09:20
06/23/17
06/23
09:20
06/23/17
09:20
Recommendations
ASML analyst commentary  »

ASML shares could double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.